The New Faecal Calprotectin Care Pathway, developed by Dr James Turvill, Consultant Gastroenterologist at York Teaching Hospitals NHS Foundation Trust, and implemented by the Yorkshire and Humber AHSN, supports the implementation of NICE guidance DG11, for the detection of inflammation in the bowel (i.e. IBS vs IBD).
The innovative and sensitive pathway based will help GPs make the difficult discrimination between irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Using guidelines from the pilot programme in York, the pathway has been implemented in nine Clinical Commissioning Groups (CCGs). There are plans to implement in five more with the aim of influencing future NICE guidance.
